Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license research and collaborat... Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single in-office intravitreal IVT injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust sustained treatment response reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor VEGF injections. Show more
REDWOOD CITY, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM) today announced that on September 3, 2024, the Compensation Committee of Adverumβs Board of...
REDWOOD CITY, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for...
- 6E10 dose of Ixo-vec selected for Phase 3 pivotal trials - LUNA 26-week interim analysis presented at ASRS 2024 demonstrating a potential best-in-class product profile of Ixo-vec, with similar...
REDWOOD CITY, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for...
REDWOOD CITY, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage company pioneering the use of gene therapy as a new standard of care for...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.2 | 2.74348422497 | 7.29 | 7.6889 | 6.97 | 240740 | 7.28125211 | CS |
4 | 0.12 | 1.62822252374 | 7.37 | 7.6889 | 6.54 | 160441 | 7.12192513 | CS |
12 | 0.51 | 7.30659025788 | 6.98 | 10.14 | 6.39 | 278025 | 7.71713754 | CS |
26 | -8.26 | -52.4444444444 | 15.75 | 16.435 | 6.38 | 311634 | 8.57805708 | CS |
52 | -8.61 | -53.4782608696 | 16.1 | 29.8 | 6.38 | 760934 | 15.56148214 | CS |
156 | -15.11 | -66.8584070796 | 22.6 | 29.8 | 5.31 | 852178 | 15.01299041 | CS |
260 | -57.11 | -88.4055727554 | 64.6 | 269.8 | 5.31 | 1116995 | 56.37112288 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.